Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointment ...
Oncternal Expands Leadership Team with Appointment of Frank Hsu, M.D., as Chief Medical Officer, and Rajesh Krishnan, Ph.D., as Senior VP CMC and Manufacturing August 28, 2019 04:01 PM Eastern ...
Rajesh Krishnan owns 44,019 units of Common Stock which is worth $196,764.93. From 2021 to 2024 Rajesh Krishnan acquired a total of 72,992 shares in Oncternal Therapeutics, Inc., Rajesh also disposed ...
Rajesh Krishnan is an Indian melody playback singer and film actor. Although he is popularly known for his works in Kannada films, he has sung 5000 songs in Kannada, 500 in Telugu and more than 250 ...
SAN DIEGO--(BUSINESS WIRE)--Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biotechnology company developing potential first-in-class product candidates for cancers with critical unmet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback